- Home
- CRBU vs ENX Comparison
CRBU vs ENX Comparison
Compare CRBU & ENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- ENX
- Stock Information
- Founded
- CRBU 2011
- ENX 2002
- Country
- CRBU United States
- ENX United States
- Employees
- CRBU N/A
- ENX N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- ENX Finance/Investors Services
- Sector
- CRBU Health Care
- ENX Finance
- Exchange
- CRBU Nasdaq
- ENX Nasdaq
- Market Cap
- CRBU 165.8M
- ENX 169.0M
- IPO Year
- CRBU 2021
- ENX N/A
- Fundamental
- Price
- CRBU $1.72
- ENX $9.95
- Analyst Decision
- CRBU Strong Buy
- ENX
- Analyst Count
- CRBU 3
- ENX 0
- Target Price
- CRBU $6.67
- ENX N/A
- AVG Volume (30 Days)
- CRBU 656.9K
- ENX 25.4K
- Earning Date
- CRBU 11-05-2025
- ENX 01-01-0001
- Dividend Yield
- CRBU N/A
- ENX 3.94%
- EPS Growth
- CRBU N/A
- ENX N/A
- EPS
- CRBU N/A
- ENX 0.16
- Revenue
- CRBU $9,121,000.00
- ENX N/A
- Revenue This Year
- CRBU $9.23
- ENX N/A
- Revenue Next Year
- CRBU N/A
- ENX N/A
- P/E Ratio
- CRBU N/A
- ENX $61.00
- Revenue Growth
- CRBU N/A
- ENX N/A
- 52 Week Low
- CRBU $0.66
- ENX $7.84
- 52 Week High
- CRBU $3.00
- ENX $10.07
- Technical
- Relative Strength Index (RSI)
- CRBU 42.15
- ENX 74.61
- Support Level
- CRBU $1.78
- ENX $9.38
- Resistance Level
- CRBU $1.94
- ENX $9.78
- Average True Range (ATR)
- CRBU 0.11
- ENX 0.09
- MACD
- CRBU -0.02
- ENX 0.04
- Stochastic Oscillator
- CRBU 1.33
- ENX 92.14
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
About ENX Eaton Vance New York Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance New York Municipal Bond Fund is principally engaged in managing investment funds and providing investment management and advisory services to high-net-worth individuals and institutions. It is a non-diversified, closed-end investment company. Its objective is to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in specified state.